Subrahmanyam S, Cronan J E
Departments of Microbiology, University of Illinois, Urbana, Illinois 61801, USA.
J Bacteriol. 1998 Sep;180(17):4596-602. doi: 10.1128/JB.180.17.4596-4602.1998.
beta-Ketoacyl-acyl carrier protein (ACP) synthetase II (KAS II) is one of three Escherichia coli isozymes that catalyze the elongation of growing fatty acid chains by condensation of acyl-ACP with malonyl-ACP. Overexpression of this enzyme has been found to be extremely toxic to E. coli, much more so than overproduction of either of the other KAS isozymes, KAS I or KAS III. The immediate effect of KAS II overproduction is the cessation of phospholipid synthesis, and this inhibition is specifically due to the blockage of fatty acid synthesis. To determine the cause of this inhibition, we examined the intracellular pools of ACP, coenzyme A (CoA), and their acyl thioesters. Although no significant changes were detected in the acyl-ACP pools, the CoA pools were dramatically altered by KAS II overproduction. Malonyl-CoA increased to about 40% of the total cellular CoA pool upon KAS II overproduction from a steady-state level of around 0.5% in the absence of KAS II overproduction. This finding indicated that the conversion of malonyl-CoA to fatty acids had been blocked and could be explained if either the conversion of malonyl-CoA to malonyl-ACP and/or the elongation reactions of fatty acid synthesis had been blocked. Overproduction of malonyl-CoA:ACP transacylase, the enzyme catalyzing the conversion of malonyl-CoA to malonyl-ACP, partially relieved the toxicity of KAS II overproduction, consistent with a model in which high levels of KAS II blocks access of the other KAS isozymes to malonyl-CoA:ACP transacylase.
β-酮脂酰-酰基载体蛋白(ACP)合成酶II(KAS II)是大肠杆菌三种同工酶之一,它通过酰基-ACP与丙二酸单酰-ACP的缩合反应催化脂肪酸链的延长。已发现该酶的过表达对大肠杆菌具有极强的毒性,比其他两种KAS同工酶KAS I或KAS III的过量产生毒性大得多。KAS II过量产生的直接影响是磷脂合成停止,这种抑制作用具体是由于脂肪酸合成受阻。为了确定这种抑制作用的原因,我们检测了细胞内ACP、辅酶A(CoA)及其酰基硫酯的水平。虽然在酰基-ACP水平上未检测到显著变化,但KAS II的过量产生使CoA水平发生了显著改变。在没有KAS II过量产生时,丙二酸单酰-CoA的稳态水平约为总细胞CoA池的0.5%,而KAS II过量产生时,丙二酸单酰-CoA增加到总细胞CoA池的约40%。这一发现表明丙二酸单酰-CoA向脂肪酸的转化受阻,如果丙二酸单酰-CoA向丙二酸单酰-ACP的转化和/或脂肪酸合成的延长反应受阻,就可以解释这一现象。催化丙二酸单酰-CoA转化为丙二酸单酰-ACP的丙二酸单酰-CoA:ACP转酰基酶的过量产生部分缓解了KAS II过量产生的毒性,这与一种模型一致,即高水平的KAS II阻止了其他KAS同工酶接近丙二酸单酰-CoA:ACP转酰基酶。